medical oncology newsroom
Stephen Keysar, PhD, Promoted to Associate Professor
We are pleased to announce the promotion of Dr. Stephen Keysar from Assistant Research Professor to Associate Research Professor.
Defining MET Amplification as Drivers for NSCLC
Dr. Camidge has participated in one of the largest efforts to prove that MET-inhibitor drugs are effective for treating patients with NSCLC driven by MET amplification.
New Hope for Women with Metastatic Breast Cancer
Traci Lyons, PhD, suggests semaphorin 7 may be particularly important in estrogen receptor (ER) positive breast cancer because cancer cells in ER-positive breast cancer have receptors that allow them to use the hormone estrogen to grow.